Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Neither outcome is guaranteed, and Lilly's own disclaimer states there is no guarantee that retatrutide will receive regulatory approval
The surge in demand for GLP-1 medications attracted a wide range of virtual care companies
After treatment, SBR was 92.9% in the 36-week SSR group compared with 95.2% in the 48-week SSR group by PPS analysis ( p =1.000)
Federal insurers like TRICARE and Medicaid also cover some obesity treatments, and Medicare is currently working to overcome a regulatory barrier to covering GLP-1s
The retatrutide pricing guide tracks current market rates across different supplier tiers
Dor S, Takahashi M, Ferris CD, Zakhary R, Hester LD, Guastella D et al
US$ 27.42
US$ 23.74
US$ 21.54
US$ 25.78
US$ 26.45
